IP Library Granted Patent US 12,502,548
Granted Patent B2
US 12,502,548 · App. 18/089,798 · Granted Dec 23, 2025

Reducing electrosensation whilst treating a subject using alternating electric fields by using larger cathodes and smaller anodes

Inventor: Kristen W. Carlson (Concord, MA)
Assignee: Novocure GmbH
A61N1/40A61N1/36002A61N1/3616A61N1/3615
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12,502,548
App. No.
18/089,798
Filed
Dec 28, 2022
Granted
Dec 23, 2025
Kind
B2
Art Unit
3792
USPC
607/76
Abstract

When treating a subject using alternating electric fields (e.g., using TTFields to treat a tumor), some subjects experience an electrosensation effect. This electrosensation can be reduced or eliminated by applying a plurality of electrical pulses between two sets of electrode elements positioned on opposite sides of the target region. During the pulses, one set of electrode elements operate as the anode and the other set of electrode elements operate as the cathode. Electrosensation is reduced or eliminated because the collective area of the cathode is at least twice as large as the anode. An electrical signal with the opposite polarity is also applied to charge-balance the plurality of electrical pulses. The plurality of electrical pulses has an average amplitude that is at least twice the average amplitude of the charge-balancing signal.

Claims (37)

1 . A method of treating a target region of a subject's body with an electric field, the method comprising:

applying a plurality of electrical pulses between at least one first electrode element and at least one second electrode element, wherein the at least one first electrode element and the at least one second electrode element are positioned on opposite sides of the target region, wherein the at least one first electrode element has a first collective area, wherein the at least one second electrode element has a second collective area that is at least twice as large as the first collective area, and wherein the plurality of electrical pulses has a polarity such that the at least one first electrode element operates as an anode and the at least one second electrode element operates as a cathode; and

applying an electrical signal between the at least one first electrode element and the at least one second electrode element, wherein the electrical signal has a polarity such that the at least one first electrode element operates as a cathode and the at least one second electrode element operates as an anode, wherein the electrical signal charge-balances the plurality of electrical pulses, and wherein the electrical signal has an average amplitude,

wherein the plurality of electrical pulses has an average amplitude that is at least twice the average amplitude of the electrical signal,

wherein the plurality of electrical pulses has a pulse repetition rate between 50,000 and 1,000,000 pulses per second, and

wherein the plurality of electrical pulses has a waveform that collectively resembles (i) a sequence of rectangular pulses with a 50% duty cycle, (ii) a rectified sinusoid, or (iii) an offset sinusoid.

2 . The method of claim 1 , wherein the plurality of electrical pulses comprises at least 1000 groups of electrical pulses, with each group including at least 1000 electrical pulses, with breaks having a duration of at least 10 ms disposed between adjacent groups, and wherein the electrical signal is applied during the breaks.

3 . The method of claim 2 , wherein the electrical signal is not applied during intervals of time that lie between adjacent pulses within a given group of electrical pulses.

4 . The method of claim 2 , wherein the electrical signal is also applied during intervals of time that lie between adjacent pulses within a given group of electrical pulses.

5 . The method of claim 1 , wherein the steps of (a) applying the plurality of electrical pulses and (b) applying the electrical signal are repeated in an alternating sequence at least 10,000 times.

6 . The method of claim 5 , wherein the plurality of electrical pulses has an average amplitude that is at least four times the average amplitude of the electrical signal, and

wherein the second collective area is at least four times as large as the first collective area.

7 . The method of claim 1 , wherein the plurality of electrical pulses has an average amplitude that is at least four times the average amplitude of the electrical signal, and

wherein the second collective area is at least four times as large as the first collective area.

8 . The method of claim 1 , wherein the plurality of electrical pulses comprises a plurality of rectangular pulses with a 50% duty cycle.

9 . The method of claim 1 , wherein the step of applying the plurality of electrical pulses between the at least one first electrode element and the at least one second electrode element induces an electric field in the target region that provides an anti-tumor effect.

10 . The method of claim 1 , wherein the step of applying the plurality of electrical pulses between the at least one first electrode element and the at least one second electrode element induces an electric field in the target region that increases the permeability of the subject's blood-brain-barrier.

11 . The method of claim 1 , wherein the at least one first electrode element comprises a first subset of a first array of electrode elements, wherein the at least one second electrode element comprises a second subset of a second array of electrode elements, and wherein the second subset contains at least twice as many electrode elements as the first subset.

12 . The method of claim 1 , wherein the plurality of electrical pulses has a waveform that collectively resembles a rectified sinusoid.

13 . The method of claim 1 , wherein the plurality of electrical pulses has a waveform that collectively resembles an offset sinusoid.

14 . An apparatus for treating a target region of a subject's body with an electric field, the apparatus comprising:

a signal generator configured to output a plurality of electrical pulses between at least one first electrode element and at least one second electrode element, wherein the plurality of electrical pulses has a polarity such that the at least one first electrode element operates as an anode and the at least one second electrode element operates as a cathode,

wherein the signal generator is further configured to output an electrical signal between the at least one first electrode element and the at least one second electrode element, the electrical signal having a polarity such that the at least one first electrode element operates as a cathode and the at least one second electrode element operates as an anode, wherein the electrical signal charge-balances the plurality of electrical pulses, and wherein the electrical signal has an average amplitude, and

wherein the plurality of electrical pulses has an average amplitude that is at least twice the average amplitude of the electrical signal,

wherein the plurality of electrical pulses has a pulse repetition rate between 50,000 and 1,000,000 pulses per second, and

wherein the plurality of electrical pulses has a waveform that collectively resembles (i) a sequence of rectangular pulses with a 50% duty cycle, (ii) a rectified sinusoid, or (iii) an offset sinusoid.

15 . The apparatus of claim 14 , further comprising the at least one first electrode element and the at least one second electrode element,

wherein the at least one first electrode element and the at least one second electrode element are configured for positioning on or in the subject's body on opposite sides of the target region, wherein the at least one first electrode element has a first collective area, and wherein the at least one second electrode element has a second collective area that is at least twice as large as the first collective area.

16 . The apparatus of claim 15 , wherein the plurality of electrical pulses has an average amplitude that is at least four times the average amplitude of the electrical signal, and

wherein the second collective area is at least four times as large as the first collective area.

17 . The apparatus of claim 16 , wherein the plurality of electrical pulses comprises at least 1000 groups of electrical pulses, with each group including at least 1000 electrical pulses, with breaks having a duration of at least 10 ms disposed between adjacent groups, and wherein the signal generator is configured to output the electrical signal during the breaks.

18 . The apparatus of claim 17 , wherein the signal generator is configured not to output the electrical signal during intervals of time that lie between adjacent pulses within a given group of electrical pulses.

19 . The apparatus of claim 17 , wherein the signal generator is configured to also output the electrical signal during intervals of time that lie between adjacent pulses within a given group of electrical pulses.

20 . The apparatus of claim 14 , wherein the plurality of electrical pulses comprises a plurality of rectangular pulses with a 50% duty cycle.

21 . The apparatus of claim 14 , wherein the at least one first electrode element comprises a first subset of a first array of electrode elements, wherein the at least one second electrode element comprises a second subset of a second array of electrode elements, and wherein the second subset contains at least twice as many electrode elements as the first subset.

22 . The apparatus of claim 14 , wherein the plurality of electrical pulses has a waveform that collectively resembles a rectified sinusoid.

23 . The apparatus of claim 14 , wherein the plurality of electrical pulses has a waveform that collectively resembles an offset sinusoid.

Assignments (2)
PATENT SECURITY AGREEMENT Recorded May 4, 2024
From: NOVOCURE GMBH (SWITZERLAND)
To: BIOPHARMA CREDIT PLC
Reel/Frame 067315/0399 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 15, 2023
From: CARLSON, KRISTEN W.
To: NOVOCURE GMBH
Reel/Frame 062708/0195 →
Continuity (2)
Provisional Application 63294673 · Dec 29, 2021
Related Publication 20230201616A1 · Jun 29, 2023
References Cited (139)
US 4608985A · Crish et al. · 1986 [cited by applicant]
US 6868289B2 · Palti · 2005 [cited by applicant]
US 7016725B2 · Palti · 2006 [cited by applicant]
US 7089054B2 · Palti · 2006 [cited by applicant]
US 7136699B2 · Palti · 2006 [cited by applicant]
US 7333852B2 · Palti · 2008 [cited by applicant]
US 7467011B2 · Palti · 2008 [cited by applicant]
US 7519420B2 · Palti · 2009 [cited by applicant]
US 7565205B2 · Palti · 2009 [cited by applicant]
US 7565206B2 · Palti · 2009 [cited by applicant]
US 7599745B2 · Palti · 2009 [cited by applicant]
US 7599746B2 · Palti · 2009 [cited by applicant]
US 7706890B2 · Palti · 2010 [cited by applicant]
US 7715921B2 · Palti · 2010 [cited by applicant]
US 7805201B2 · Palti · 2010 [cited by applicant]
US 7890183B2 · Palti et al. · 2011 [cited by applicant]
US 7912540B2 · Palti · 2011 [cited by applicant]
US 7917227B2 · Palti · 2011 [cited by applicant]
US 8019414B2 · Palti · 2011 [cited by applicant]
US 8027738B2 · Palti · 2011 [cited by applicant]
US 8170684B2 · Palti · 2012 [cited by applicant]
US 8175698B2 · Palti et al. · 2012 [cited by applicant]
US 8229555B2 · Palti · 2012 [cited by applicant]
US RE43618E · Palti · 2012 [cited by applicant]
US 8244345B2 · Palti · 2012 [cited by applicant]
US 8406870B2 · Palti · 2013 [cited by applicant]
US 8447395B2 · Palti et al. · 2013 [cited by applicant]
US 8447396B2 · Palti et al. · 2013 [cited by applicant]
US 8465533B2 · Palti · 2013 [cited by applicant]
US 8706261B2 · Palti · 2014 [cited by applicant]
US 8715203B2 · Palti · 2014 [cited by applicant]
US 8718756B2 · Palti · 2014 [cited by applicant]
US 8764675B2 · Palti · 2014 [cited by applicant]
US 9023090B2 · Palti · 2015 [cited by applicant]
US 9023091B2 · Palti · 2015 [cited by applicant]
US 9039674B2 · Palti et al. · 2015 [cited by applicant]
US 9056203B2 · Palti et al. · 2015 [cited by applicant]
US 9440068B2 · Palti et al. · 2016 [cited by applicant]
US 9655669B2 · Palti et al. · 2017 [cited by applicant]
US 9750934B2 · Palti et al. · 2017 [cited by applicant]
US 9910453B2 · Wasserman et al. · 2018 [cited by applicant]
US 10188851B2 · Wenger et al. · 2019 [cited by applicant]
US 10441776B2 · Kirson et al. · 2019 [cited by applicant]
US 10779875B2 · Palti et al. · 2020 [cited by applicant]
US 10967167B2 · Hagemann et al. · 2021 [cited by applicant]
US 11103698B2 · Chang et al. · 2021 [cited by applicant]
US 11191956B2 · Giladi et al. · 2021 [cited by applicant]
US 20040176804A1 · Palti · 2004 [cited by applicant]
US 20060167499A1 · Palti · 2006 [cited by applicant]
US 20060276858A1 · Palti · 2006 [cited by applicant]
US 20070225766A1 · Palti · 2007 [cited by applicant]
US 20070239213A1 · Palti · 2007 [cited by applicant]
US 20090076366A1 · Palti · 2009 [cited by applicant]
US 20090270943A1 · Maschino · 2009 [cited by applicant]
US 20120029419A1 · Palti · 2012 [cited by applicant]
US 20120071950A1 · Archer · 2012 [cited by examiner]
US 20120283726A1 · Paiti · 2012 [cited by applicant]
US 20140277259A1 · Rosenberg et al. · 2014 [cited by applicant]
US 20140330268A1 · Palti et al. · 2014 [cited by applicant]
US 20170113047A1 · Chang · 2017 [cited by examiner]
US 20170120041A1 · Wenger et al. · 2017 [cited by applicant]
US 20170215939A1 · Palti et al. · 2017 [cited by applicant]
US 20170281934A1 · Giladi et al. · 2017 [cited by applicant]
US 20180001075A1 · Kirson et al. · 2018 [cited by applicant]
US 20180008708A1 · Giladi et al. · 2018 [cited by applicant]
US 20180050200A1 · Wasserman et al. · 2018 [cited by applicant]
US 20180110992A1 · Parramon et al. · 2018 [cited by applicant]
US 20180160933A1 · Urman et al. · 2018 [cited by applicant]
US 20180202991A1 · Giladi et al. · 2018 [cited by applicant]
US 20180280687A1 · Carter et al. · 2018 [cited by applicant]
US 20190117956A1 · Wenger et al. · 2019 [cited by applicant]
US 20190117963A1 · Travers et al. · 2019 [cited by applicant]
US 20190224474A1 · Yang et al. · 2019 [cited by applicant]
US 20190308016A1 · Wenger et al. · 2019 [cited by applicant]
US 20190329039A1 · Marnfeldt · 2019 [cited by examiner]
US 20200001069A1 · Kirson et al. · 2020 [cited by applicant]
US 20200009376A1 · Chang et al. · 2020 [cited by applicant]
US 20200009377A1 · Chang et al. · 2020 [cited by applicant]
US 20200016067A1 · Gotlib et al. · 2020 [cited by applicant]
US 20200023179A1 · Bomzon et al. · 2020 [cited by applicant]
US 20200061360A1 · Hagemann et al. · 2020 [cited by applicant]
US 20200061361A1 · Hagemann et al. · 2020 [cited by applicant]
US 20200069937A1 · Naveh et al. · 2020 [cited by applicant]
US 20200078582A1 · Alon et al. · 2020 [cited by applicant]
US 20200108031A1 · Borst et al. · 2020 [cited by applicant]
US 20200114141A1 · Bomzon et al. · 2020 [cited by applicant]
US 20200114142A1 · Bomzon et al. · 2020 [cited by applicant]
US 20200121728A1 · Wardak et al. · 2020 [cited by applicant]
US 20200129761A1 · Bomzon et al. · 2020 [cited by applicant]
US 20200146586A1 · Naveh et al. · 2020 [cited by applicant]
US 20200155835A1 · Wasserman et al. · 2020 [cited by applicant]
US 20200171297A1 · Kirson et al. · 2020 [cited by applicant]
US 20200179512A1 · Giladi et al. · 2020 [cited by applicant]
US 20200219261A1 · Shamir et al. · 2020 [cited by applicant]
US 20200269037A1 · Hagemann et al. · 2020 [cited by applicant]
US 20200269041A1 · Zeevi et al. · 2020 [cited by applicant]
US 20200368525A1 · Maag et al. · 2020 [cited by applicant]
US 20200384266A1 · Wang · 2020 [cited by examiner]
US 20210023372A1 · Musallam · 2021 [cited by examiner]
US 20210031031A1 · Wasserman et al. · 2021 [cited by applicant]
US 20210038584A1 · Voloshin-Sela · 2021 [cited by applicant]
US 20210060334A1 · Avraham et al. · 2021 [cited by applicant]
US 20210069503A1 · Tran et al. · 2021 [cited by applicant]
US 20210138233A1 · Deslauriers · 2021 [cited by applicant]
US 20210162228A1 · Urman et al. · 2021 [cited by applicant]
US 20210187277A1 · Wasserman et al. · 2021 [cited by applicant]
US 20210196348A1 · Wasserman · 2021 [cited by applicant]
US 20210199640A1 · Patel et al. · 2021 [cited by applicant]
US 20210203250A1 · Wasserman · 2021 [cited by applicant]
US 20210268247A1 · Story et al. · 2021 [cited by applicant]
US 20210299440A1 · Deslauriers et al. · 2021 [cited by applicant]
US 20210308446A1 · Alon et al. · 2021 [cited by applicant]
US 20210330950A1 · Hagemann et al. · 2021 [cited by applicant]
US 20210346694A1 · Wasserman et al. · 2021 [cited by applicant]
US 20210379362A1 · Smith et al. · 2021 [cited by applicant]
US 20210408383A1 · Kalra et al. · 2021 [cited by applicant]
US 20220095997A1 · Wasserman · 2022 [cited by applicant]
US 20220096821A1 · Kirson et al. · 2022 [cited by applicant]
US 20220118249A1 · Bomzon et al. · 2022 [cited by applicant]
US 20220161028A1 · Giladi et al. · 2022 [cited by applicant]
US 20220193435A1 · Wasserman et al. · 2022 [cited by applicant]
US 20220233848A1 · Gad · 2022 [cited by examiner]
US 20220267445A1 · Tran et al. · 2022 [cited by applicant]
US 20220280787A1 · Bomzon et al. · 2022 [cited by applicant]
US 20220288395A1 · Voloshin-Sela et al. · 2022 [cited by applicant]
US 20220313992A1 · Wasserman · 2022 [cited by applicant]
US 20220323753A1 · Voloshin-Sela et al. · 2022 [cited by applicant]
US 20230000384A1 · Wasserman et al. · 2023 [cited by applicant]
US 20230001197A1 · Wasserman et al. · 2023 [cited by applicant]
US 20230001221A1 · Farber · 2023 [cited by applicant]
US 20230009366A1 · Voloshin-Sela et al. · 2023 [cited by applicant]
US 20230019638A1 · Wasserman · 2023 [cited by applicant]
US 20230037806A1 · Wasserman et al. · 2023 [cited by applicant]
US 20230043071A1 · Wasserman et al. · 2023 [cited by applicant]
EP 3381507A1 · 2018 [cited by applicant]
EP 3623004A1 · 2020 [cited by applicant]
WO 2020131857A1 · 2020 [cited by applicant]
International Search Report and Written Opinion issued in application No. PCT/IB2022/062822 dated Mar. 13, 2023. [cited by applicant]
Koivuniemi et al., “Asymmetric Versus Symmetric Pulses for Cortical Microstimulation,” IEEE, vol. 19, No. 5, pp. 468-476, Oct. 2011. [cited by applicant]